NanOlogy Names John M. Goldberg, MD, as Fractional CMO
Fort Worth-based NanOlogy, a clinical-stage oncology company, on Tuesday announced the appointment of John M. Goldberg as fractional…
NanOlogy Advances New DIPG Drug Toward 2026 Trial
NanOlogy, a Fort Worth-based private clinical-stage oncology company, announced Thursday a major step forward in its effort to…